Skip to content

Tribute Pharmaceuticals Canada Inc.

company.status.inactive

CIK 1159019fmd_0BBVKDJHRD53SEXVKQN2AQ5C5AManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2015, 20 periods

Income Statement · Annual · Millions · CAD
Line itemFY2011FY2012FY2013FY2014
Total revenues4121317
Cost of revenue1122
Gross profit2569
Research and development00––
Selling, general and administrative39910
Total operating expenses3101112
Operating income(1)(4)(5)(3)
Interest expense0011
Interest and investment income0000
Net income from continuing operations(1)(4)(5)(3)
Net income(1)(3)(7)(6)
Net income to common shareholders(1)(3)(7)(6)